4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-292985
Chief Executive Officer sold 49,666 shares at $240.25 ($11,932,257)
- Chief Executive Officer acquired 49,666 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TABUTEAU HERRIOT Chief Executive Officer | 2026-07-01 | Option exercise 10b5-1 | +49,666 | $4.95 | $245,847 | 56,895 | D |
| TABUTEAU HERRIOT Chief Executive Officer | 2026-07-01 | Sale 10b5-1 | −49,666 | $240.25 | $11,932,257 | 7,229 | D |
| Derivatives | |||||||
| TABUTEAU HERRIOT Chief Executive Officer | 2026-07-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −49,666 | 49,664 | D | ||
| Open-market sales · 49,666 sh · avg $240.25 · $11,932,257 | |||||||
Loading xslF345X06/ownership.xml…